EIF2AK3 and Alzheimer disease: Further studies also showed that suppression of PERK using a small molecule PERK antagonist, GSK2606414, prevented tau-mediated neuropathology, behavioral defects, and alleviated long-term depression (LTD), another synaptic plasticity impairment seen in AD [108,109,110].